Management of Adverse Events in Cancer Patients Treated With PD-1/PD-L1 Blockade: Focus on Asian Populations

The interaction between programmed cell death protein 1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1) induces exhaustions of cytotoxic lymphocytes in the tumor microenvironment, which facilitates tumor immune evasion. PD-1/PD-L1 blockade therapy, which prevents the receptors and ligands fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jiqiao, He, Xiujing, Lv, Qing, Jing, Jing, Shi, Hubing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614522/
https://www.ncbi.nlm.nih.gov/pubmed/31312140
http://dx.doi.org/10.3389/fphar.2019.00726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614522/
https://www.ncbi.nlm.nih.gov/pubmed/31312140
http://dx.doi.org/10.3389/fphar.2019.00726

Ejemplares similares